Pleiomorphic Adenoma Gene-Like 1 (PLAGL1) Peptide
Quick Overview for Pleiomorphic Adenoma Gene-Like 1 (PLAGL1) Peptide (ABIN981836)
Target
Origin
Source
Application
-
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-PLAGL1 antibody (Catalog #: ARP38852_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- PLAGL1 (Pleiomorphic Adenoma Gene-Like 1 (PLAGL1))
-
Background
-
PLAGL1 is a C2H2 zinc finger protein with transactivation and DNA-binding activity. This gene has been shown to exhibit antiproliferative activities and is a tumor suppressor gene candidate.This gene encodes a C2H2 zinc finger protein with transactivation and DNA-binding activity. This gene has been shown to exhibit antiproliferative activities and is a tumor suppressor gene candidate. Two transcript variants encoding different isoforms have been found for this gene.
Alias Symbols: ZAC, LOT1, ZAC1
Protein Interaction Partner: PLAGL1,SMAD3,TP53,DAXX,PML,TP53
Protein Size: 411 -
Molecular Weight
- 45 kDa
-
Gene ID
- 5325
-
NCBI Accession
- NM_002656, NP_002647
-
UniProt
- Q9UM63
Target
-